Clinical Outcomes: Overview


AVITA Medical is committed to pursuing the full potential of its innovative regenerative technology platform to advance patient care in skin restoration, which includes a number of areas with significant unmet medical need. Currently approved in the U.S. for the acute treatment of thermal burns, studies are underway assessing the RECELL® System for the treatment of soft tissue reconstruction, pediatric scalds and vitiligo. The team is also conducting early-stage research into epidermolysis bullosa and rejuvenation, and exploring the use of the RECELL® System for treatment of chronic wounds.

Globally, the RECELL® System is approved for additional skin applications, such as chronic and traumatic wounds, scar revision, and vitiligo, which provides AVITA Medical with valuable experience and confidence in pursuing expanded labeling in the U.S. following the completion of additional clinical trials.